Human metapneumovirus (HMPV) is an important cause of respiratory tract infections. The mechanism by which its fusion (F) protein is responsible for variable cytopathic effects in vitro remains unknown. We aligned the F sequences of the poorly fusogenic B2/CAN98-75 strain and the hyperfusogenic A1/C-85473 strain and identified divergent residues located in the two functional heptad repeats domains (HRA and HRB). We generated recombinant viruses by inserting the mutations N135T-G139N-T143K-K166E-E167D in HRA and/or K479R-N482S in HRB, corresponding to swapped sequences from C-85473, into CAN98-75 background and investigated their impact on in vitro phenotype and fusogenicity. We demonstrated that the five HRA mutations enhanced the fusogenicity of the recombinant rCAN98-75 virus, almost restoring the phenotype of the wild-type rC-85473 strain, whereas HRB substitutions alone had no significant effect on cell-cell fusion. Altogether, our results support the importance of the HRA domain for an HMPV-triggered fusion mechanism and identify key residues that modulate syncytium formation.
Human metapneumovirus (HMPV) is an important respiratory pathogen affecting children and immunocompromised and elderly individuals [1] . HMPV belongs to the Pneumoviridae family and is classified into two main lineages (A and B), each of which is divided into two or three sublineages (A1, A2a, A2b, B1 and B2) [2] [3] [4] [5] [6] . The clinical signs associated with HMPV are similar to those associated with another pneumovirus, the human respiratory syncytial virus (HRSV), ranging from mild respiratory problems to bronchiolitis and pneumonia, even though little is known about factors associated with disease severity [7] [8] [9] . There are currently no specific antiviral agents or vaccines approved for this pathogen, despite the fact that several promising strategies are under evaluation [10] .
The HMPV fusion (F) protein is responsible for viral entry into host cells through an autonomous fusion mechanism [11, 12] . In vitro, the HMPV F protein also promotes the cell-cell fusion that results in variable cytopathic effects (CPE), from HRSV-like syncytia to focal cell rounding, depending on the HMPV strains [13] . As a class I viral fusion protein, the function of HMPV F protein implies an important refolding from a trimeric metastable active prefusion form to an irreversible post-fusion conformation, which depends on the interaction between the two functional domains, heptad repeats A and B (HRA and HRB) [14, 15] . Indeed, starting from a spring-loaded structure in a globular head of pre-fusion form, the HRA refolds completely to interact with the HRB helix located in the rod-like stalk. The resulting six-helix bundle structure (6HB), which is characteristic of activated F protein in postfusion conformation, leads to the formation of the fusion pore [11, 14] . We do not fully understand why some HMPV strains produce large syncytia in vitro whereas others do not and, more broadly, the role of HMPV F HR functional domains in the fusion mechanism is still poorly characterized compared to that of other class I viral fusion proteins.
We previously identified two HMPV strains (A1/C-85473 and B2/CAN98-75, GenBank accession numbers KM408076.1 and AY145289.1) that respectively induce or do not induce the formation of large syncytia, and we further demonstrated by generating chimeric recombinant viruses that swapping of the F genes was sufficient to alter or restore the respective fusogenic phenotype of these two strains in vitro [16] . In addition, it has already been reported in several studies on paramyxoviruses and pneumoviruses, including ours, that the energy threshold required to trigger conformational changes of fusion proteins depends on key residues within HR domains and their proximal regions, especially those interacting with the F2 subunit in the prefusion conformation or interacting in the 6HB in the postfusion conformation [17, 18] . In consequence, few mutations could impact greatly on F fusogenic capacity [19, 20] . Some amino acids in the F2 subunit (residues 51, 54 and 56) or between the two HR domains (residues 294, 296, 396, 404 and 435) have been reported to influence HMPV fusogenicity, altering electrostatic interactions or histidine protonation, but this could not explain the divergent fusogenic phenotype of our two HMPV strains CAN98-75 and C-85473, as their respective sequences are identical at those positions [18, [20] [21] [22] ].
In the current study, we identified a few divergent amino acids in the HR regions between the two viruses B2/ CAN98-75 and A1/C-85473 (Fig. 1a) and aimed to characterize their implication in the HMPV fusogenic phenotype. The overall amino acid sequence identity between HMPV members of the A and B lineages is greater than 90 %, with identities of 90.7 and 92.9 % for the HRA and HRB regions, respectively [23] [24] [25] . Of the 29 amino acid differences in the F protein sequence between these two HMPV strains, five substitutions are located in the HRA and two are located in the HRB (Fig. 1a) . Consequently, by reverse genetics we generated three recombinant HMPV viruses based on the CAN98-75 viral background, expressing constitutively the GFP protein, in which the HRA or/and HRB domains of the F gene were mutated according to the sequence of the highly fusogenic C-85473 strain (Fig. 1b) . All recombinant viruses were successfully generated by site-directed mutagenesis of rCAN98-75 full-length genomic plasmids and recovered as previously described by Aerts et al. [16] . Three constructions were obtained: rCAN98-75-FHRA with the mutations N135T-G139N-T143K-K166E-E167D, rCAN98-75-FHRB with the mutations K479R-N482S and rCAN98-75-FHRA +B with all seven of these mutations.
Firstly, we investigated the in vitro replicative capacity of all recombinant HMPV viruses in LLC-MK2 cells (ATCC CCL-7) as previously described [16] . All end-point supernatants were titrated in fluorescent focus units (f.f.u.) ml À1 using GFP expression as an infection reporter, similarly to Meng and Hotard [26] . The recombinant viruses rCAN98-75-FHRA, rCAN98-75-FHRB and rCAN98-75-FHRA+B replicated similarly to the wild-type (WT) rCAN98-75 virus, as titres increased at the same rate until day 4 but then peaked at a higher titre on day 6 (1Â10 4 , 1.6Â10 4 and 6Â10 3 f.f.u. ml
À1
, respectively), whereas the WT rCAN98-75 reached a plateau at 2.5Â10 3 f.f.u. ml À1 (Fig. 1c) . These results suggest that the modifications of the HRA and/or HRB domains in CAN98-75 background affect the viral replicative capacity. On the other hand, the WT rC-85473 replicated rapidly at higher levels on days 2 and 3 postinfection [peak titre of 4.9Â10 4 f.f.u. ml À1 at day 3, P<0.001 (Fig. 1c) ], followed by a titre drop-off at day 4 as the cell monolayer was completely destroyed, in accordance with our previous published results [16] .
We then investigated the impact of the sets of mutations on the in vitro fusogenicity by infecting LLC-MK2 cells at an m.o.i. of 1 with each HMPV recombinant virus. After a 1.5 h incubation at 37 C, 5 % CO 2 , the infection medium was replaced by semi-solid medium (OptiMEM, 0.8 % methylcellulose and 0.0002 % trypsin). At day 3 or 4 postinfection, before infected cells completely detached, cells were fixed in paraformaldehyde, washed and permeabilized with 0.1 % Triton X-100. Nuclei were stained with DAPI and representative pictures were taken using fluorescent microscopy ( Fig. 2a) . The rCAN98-75-FHRA and rCAN98-75-FHRA+B viruses differed visibly from their respective WT counterparts as they induced large syncytia formation at day 4. In contrast, the rCan98-75-FHRB virus induced more rounding cells as CPE than syncytia on day 4 ( Fig. 2a) . On the other hand, the hyperfusogenic WT rC-85473 virus rapidly induced the fusion of infected cells, resulting in earlier formation of massive syncytia on day 3 ( Fig. 2a) .
Additionally, the cell-cell fusion extent was quantified by counting the number of nuclei per infected cells. LLC-MK2 cells were infected with each HMPV recombinant virus at an m.o.i. of 0.1. On day 3 post-infection, when CPE were visible and before cells began to detach, the cells were fixed and DAPI-stained in order to count at least 10 3 nuclei included in infected cells. The mean number of nuclei per cell was 2.5±0.15 for the WT rCAN98-75 strain and 6.9±0.9 for the WT rC-85473 virus, whereas it was 4.1±0.48, 3.9 ±0.39 and 2.2±0.16 for rCAN98-75-HRA, rCAN98-75-HRA +B and rCAN98-75-FHRB, respectively, confirming that mutations in the HRA region, combined or not combined with mutations in HRB, enhanced the fusogenicity of CAN98-75, while HRB mutations alone had no effect on cell-cell fusion (Fig. 2b) . We also sorted infected cells by syncytium categories (1; 2-10; 11-25; 26-50 and more than 50 nuclei/syncytium). Similarly to rC-85473 (58.3 %), the percentage of mono-nucleated cells was reduced in rCAN98-75-HRA (58.5 %) and rCAN98-75-HRA+B (56.8 %) compared to WT rCAN98-75 (88 %) (Fig. 2c) . Accordingly, syncytia composed of 26 to 50 nuclei and those including more than 50 nuclei were also more abundant with rCAN98-75-HRA (3.8 and 0.4 %, respectively) and rCAN98-75-HRA+B (1.4 and 1.2 %, respectively) viruses, although they did not reach the extent of the WT rC-85473 strain, with 5.4 and 4.0 %, respectively (Fig. 2c) . In comparison, rCAN98-75-HRB exhibited a similar profile to WT rCAN98-75, with predominantly mono-nucleated cells (90.2 %) and small syncytia of 2-10 nuclei (8.2 %) (Fig. 2c) . We report here that the small number of modifications in the HRA domain restores, to a large extent, the fusogenic capacity of the syncytium-producing strain C-85473, whereas the two mutated residues in HRB do not contribute substantially to the syncytium formation.
Finally, we investigated the impact of these mutations on F expression at the cell surface of infected LLC-MK2 cells. AlexaFluor647 of the infected cells were measured by flow cytometry using a Becton Dickinson FACSCanto II analyzer with FACSDiva software. The data were analyzed using FlowJo software (Tree Star, Inc.) and we calculated the A647/GFP fluorescence intensity ratios for each recombinant virus, normalized to the WT rCAN98-75 values. Our results showed that HMPV F protein was significantly underexpressed at the cell surface for rCAN98-75-FHRA and rCAN98-75-FHRA+B viruses, with relative expression of 0.76±0.01 (P<0.01) and 0.76±0.05 (P<0.01), respectively. In contrast, rCAN98-75-FHRB had similar F expression (1.05±0.03) compared to WT rCAN98-75 (Fig. 2d) . On the other hand, the F protein of the hyperfusogenic rC-85473 virus was also underexpressed compared to rCAN98-75 (0.40±0.02, P<0.001) (Fig. 2d) , even though it had a better replicative capacity (Fig. 1c) , highlighting the importance of other viral proteins in HMPV replication and pathogenesis. Considering this, the underexpression of the F protein at the cell surface could be the result of protein destabilization induced by the substitutions in the HRA domain, leading to improper folding and inefficient export of the HMPV prefusion F to the cell membrane. Another explanation for the poor cell surface expression of the fusogenic viruses is the possibility that the antibody we used does not recognize the different forms of F (pre-and post-fusion) equally.
Altogether, our results suggest that one or a combination of several amino acids among the five residues 135, 139, 143, 166 and 167 in the HRA domain could have a critical role in HMPV F structure to facilitate the transition from pre-to post-fusion conformation and promote the fusogenic in vitro phenotype. Indeed, the HRA region undergoes a drastic structural rearrangement during the fusion process and it is probable that slight perturbations in the HRA domain could have important consequences for overall protein stabilization, as has already been demonstrated for other paramyxoviruses [12, 17, 18, 27] . To better understand the impact of the HRA mutations, we built homology models for both pre-fusion and post-fusion forms of HMPV F proteins (CAN98-75 and C-85473) through the SWISS-MODEL workspace (https://swissmodel.expasy.org) [28] using human RSV F protein (PDB 5C69) as the template for the pre-fusion form or slightly modifying the crystal structure of the recently published HMPV F protein post-fusion conformation (PDB 5L1X) [29] . The electrostatic potential of the protein surface was analysed with the aid of the APBS tools in PyMOL.
In pre-fusion form, the inspection of the HRA local environment indicated that this region is likely less stable in C-85473 compared to in CAN98-75 (Fig. 3a) . Indeed, the residue K166 neutralizes the negative charges E51 and E167 via salt-bridge interactions in CAN98-75, whereas these stabilizing interactions are lost in C-85473 with the introduction of E166 and D167. This results in a cluster of four negatively charged residues (E51, E164, E166 and D167) in this small patch, which is very likely the major driving force to destabilize the pre-fusion form (Fig. 3a) . Interestingly, one previous report also demonstrated the importance of charged residue clusters in the case of RSV F fusogenicity. Indeed, the change of residue 66 in proximity to positively charged R30, K65, K68, K80 and K87 led to a positive fusogenicity, whereas a change to a negative-residue Glu induced small syncytia formation [30] . These results, in addition to ours, underline the impact of amino acid charges on the triggering of fusion protein conformational rearrangement and their consecutive effect on fusogenic activity. Therefore, it would be interesting to investigate the influence of nonpolar or positively charged residues at position 166 or 167 in HMPV F protein to have a better understanding of the interactions triggering HMPV fusion. Regarding HRA residue conservation between HMPV subtypes, it is interesting to note that residue K166 is highly conserved in all HMPV strains except for 2 of the 742 HMPV F sequences available on Virus Pathogen Resource (ViPR, https://www.viprbrc. org), including the highly fusogenic C-85473 strain (with a Lys to Glu mutation at this position).
In post-fusion form, after the major structural rearrangement, it is shown that the mutated HRA residues do not participate in the internal hydrophobic interactions at the coil-coiled interface of HRA and HRB, except for residue 166, which corresponds to a position that stabilizes the 6HB structure through electrostatic binding. Thus, the residue changes in the HRA region are unlikely to impact strongly on direct interactions with HRB, but it seems that they should render the external part of the 6HB more hydrophilic, per the image of C-85473 (Fig. 3b) . This could contribute to a favourable environment towards 6HB conformation, with an overall stabilization effect that is potentially more significant than shown, owing to the trimeric nature of F protein. It is of note that, similarly to our previous work with parainfluenza viruses type 2 and 5, we attempted to generate recombinant HMPV strains carrying mutations that strengthen the hydrophobic interactions between the coiled-coil HR domains [19, 31] . However, we were unable to recover recombinant viruses with equivalent mutations by reverse genetics (data not shown), suggesting that, in the case of HMPV viruses, mutations are barely tolerated in the internal cores of HRA and HRB and could drastically impair viral replication, in contrast to parainfluenza viruses.
In this study, we have shown that mutations located in the HRB domain (K479R-N482S) had no effect on cell-cell fusion in vitro, i.e. the rCAN98-75-FHRB virus had a similar fusogenic activity to that of the WT rCAN98-75 and rCAN98-75-FHRA+B had a similar phenotype to rCAN98-75-FHRA (Fig. 2) . In fact, these mutations are not drastic, considering their electrostatic potential and polarity. Given their location in the rod-shaped stalk close to the transmembrane domain, it is possible that they are the result of protein variability in the C-terminal extremity, which is the less conserved part of the F protein. In fact, these two residues are found in all sequences of lineage A HMPV F protein (based on the alignment of 740 partial F sequences from ViPR).
One of the challenges of resolving which amino acids are involved in the fusion mechanism is the fact that, until now, very few HMPV strains have been studied and the results cannot be generalized to all HMPV strains. Our study showed that a set of residues (T135-N139-K143-E166-D167) found in the HRA region of the hyperfusogenic A1/ C-85473 HMPV virus significantly improves the fusogenicity in vitro when inserted into B2/CAN98-75 F protein.
Very likely, the destabilization of the pre-fusion form, together with the stabilization of the post-fusion form, both contribute to the enhanced fusogenicity observed for the two recombinant HMPV rCAN98-75-FHRA and rCAN98-75-FHRA+B, similar to C-85473. These results contribute to our understanding of the HMPV-F-induced fusion mechanism and highlight the role of a few key residues in the HRA domain, which impact on syncytia formation. 
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